Position in ALEC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$286,781
-$532,170 QoQ
Shares Held
142,678
-62.5% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Derivatives in ALEC
reported options exposure · as of Dec 31, 2024CallValue
$7,938
CallShares
4,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. ALEC ranks #270 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ALEC
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $286,781 | 142,678 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $818,951 | 380,908 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $209,827 | 134,506 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $728,996 | 246,283 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $481,471 | 343,909 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $415,716 | 337,982 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,938 | 4,200 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $602,243 | 318,648 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,691,113 | 362,900 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $19,572 | 4,200 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $1,631,607 | 359,385 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $19,068 | 4,200 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $2,128,978 | 353,651 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,513,713 | 440,315 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,751,490 | 424,613 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $2,592 | 400 | Call | Defined | 2023-11-14 | |
| 2023-06-30 | $2,134,539 | 355,165 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,920,768 | 471,853 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $3,916,473 | 424,320 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,484,494 | 368,340 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,016 | 100 | Call | Defined | 2022-08-12 | |
| 2022-06-30 | $2,336,565 | 229,977 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,740,289 | 332,652 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,487,313 | 411,008 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $6,141,932 | 269,147 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,661,552 | 127,775 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $2,522,673 | 125,257 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,373,303 | 90,767 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,217,676 | 115,584 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $58,656 | 2,400 | Call | Defined | 2020-08-14 | |
| 2020-06-30 | $58,656 | 2,400 | Put | Defined | 2020-08-14 | |
| 2020-06-30 | $746,444 | 30,542 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $352,826 | 14,622 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||